Healthcare
MicroPort Scientific Corporation(MCRPF)
Live Price
Offline$0.956
+0.00% today
1Y Change
-3.34%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $2.13B
- Revenue Growth
- -3.8%
- EPS Growth
- +121.6%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
MicroPort Scientific Corporation (MCRPF) is a Healthcare stock with a market cap of $2.13B and listed on OTC. The stock last traded around $0.96 and down 3.3% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -3.8%, EPS growth of +121.6%, a dividend yield of 0.0%. What stands out right now is revenue -3.8%, EPS +121.6%, free cash flow 0.0% with operating margin -3.7% and ROIC -1.2%. Valuation already assumes a fairly strong business story at P/E 37.7 and price/sales 2.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MCRPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-3.8% vs +7.6% peer median
Operating Margin
Below sector median
-3.7% vs +19.4% peer median
P/E
Near sector median
37.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Mar 31, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -3.8% and EPS is at +121.6%, with operating margin around -3.7%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 28, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 31, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Aug 29, 2025 | โ | +0.0% | +0.0% | +2.8% |
2025 Mar 28, 2025 | โ | +0.0% | +0.0% | +13.2% |
Benchmark Edge
MCRPF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MCRPF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MCRPF Max Drawdown
-48.32%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MCRPF and SPY.
Company Overview
MicroPort Scientific Corporation
Other OTC
MicroPort Scientific Corporation, an investment holding company, manufactures, and markets, and distributes medical devices in the People's Republic of China, North America, Europe, other Asian countries, South America, and internationally. The company's Cardiovascular Devices segment offers products and services for the treatment of coronary artery-related diseases; coronary stents and related delivery systems; and balloon catheters and accessories. Its Orthopedics Devices segment provides reconstructive joints, spine and trauma, and other professional implants and instruments. The company's Cardiac Rhythm Management Business segment offers defibrillators, cardiac resynchronization therapy devices, and pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Its Endovascular and Peripheral Vascular Devices segment provides products and services for the interventional treatment of thoracic and abdominal aortic aneurysm, peripheral vascular diseases, aortic dissection, and other endovascular related diseases. The company's Neurovascular Devices segment offers neurovascular therapeutic and access devices for neurovascular diseases. Its Heart Valve Business segment provides VitaFlow Transcatheter aortic valve and delivery system, VitaFlow Liberty Transcatheter aortic valve implantation and retrievable delivery systems, Alwide Plus Balloon Catheter, various transcatheter aortic valve implantation, transcatheter mitral valve, transcatheter tricuspid valve, and surgical valve products. The company's Surgical Robot Business segment designs, develops, and commercializes surgical robots comprising robot ontology, control algorithm, electrical engineering, image-based navigation, and precision imaging. Its Surgical Devices segment researches and develops, manufactures, and sells surgical devices. MicroPort Scientific Corporation was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.
- Leadership
- Jonathon W. Chen
- IPO Date
- Jan 13, 2012
- Employees
- 6.3k
- Street Address
- 1601 Zhangdong Road
- Mailing
- Shanghai, 201203
- Region
- Shanghai, CN
- Reporting Currency
- USD
- Investor Line
- 86 21 3895 4600
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 37.7
- EV/EBITDA
- 37.0
- Price/Sales
- 2.1
- Price/Book
- 1.9
Growth
- Revenue
- -3.8%
- EPS
- +121.6%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 55.2%
- Operating Margin
- -3.7%
- Net Margin
- 4.9%
- ROE
- 6.1%
- ROIC
- -1.2%
Balance Sheet
- Debt/Equity
- 1.63
- Current Ratio
- 1.45
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.